4
Changes in Ownership
MoonLake Immunotherapeutics Filed Acc 0001213900-26-002905
Options or other derivatives
- Chief Scientific Officer acquired 520,342 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Reich Kristian · Chief Scientific Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-01-07 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +520,342 | 520,342 | D |
Loading xslF345X05/ownership.xml…